Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
:GMED
Earnings Data
Report Date
Feb 19, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.09Last Year’s EPS
0.84Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call for Globus Medical was predominantly positive, with significant revenue and earnings growth, successful integration of Nevro, and strong performances in the U.S. Spine and Trauma segments. Despite these successes, there were challenges in the Enabling Technologies segment, including a decline in revenue and slower capital sales. The company's ability to adapt to market conditions and its strong cash flow generation underscore a solid financial position.Company Guidance
Record Sales and Earnings Growth
Globus Medical achieved sales of $769 million and non-GAAP diluted earnings per share of $1.18, representing growth of 22.9% and 42.6%, respectively, over the prior year quarter.
Strong Cash Flow Generation
The company delivered a record free cash flow of $213.9 million in the third quarter.
U.S. Spine Business Growth
The U.S. Spine business led with a growth of 9.6% as reported, marking 32 weeks of consecutive growth.
Successful Nevro Integration
The Nevro business, acquired earlier in the year, delivered $99.3 million in revenue and achieved a positive adjusted EBITDA margin of 16.2%.
International Growth
The International Spine business grew by 5.6% as reported, with notable performances in EMEA, Asia Pacific, and Latin America.
Trauma Segment Success
The Trauma business grew 17.2% in the third quarter, achieving the highest quarterly revenue since its inception.
GMED Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GMED Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $61.71 | $83.89 | +35.94% |
Aug 07, 2025 | $54.07 | $58.65 | +8.47% |
May 08, 2025 | $72.46 | $55.82 | -22.96% |
Feb 20, 2025 | $84.12 | $80.28 | -4.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Globus Medical (GMED) report earnings?
Globus Medical (GMED) is schdueled to report earning on Feb 19, 2026, After Close (Confirmed).
What is Globus Medical (GMED) earnings time?
Globus Medical (GMED) earnings time is at Feb 19, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GMED EPS forecast?
GMED EPS forecast for the fiscal quarter 2025 (Q4) is 1.09.